Respiratory News and Research

RSS

New study describes way to regenerate lung tissue after injury

A new collaborative study describes a way that lung tissue can regenerate after injury. The team found that lung tissue has more dexterity in repairing tissue than once thought.

13 Apr 2015

Latest findings regarding nitric oxide offer new avenues to save lives

Professor Jonathan Stamler's latest findings regarding nitric oxide have the potential to reshape fundamentally the way we think about the respiratory system - and offer new avenues to save lives. It may be time to rewrite the textbooks.

13 Apr 2015

UNICEF and OFC team up to support children affected by Pacific cyclones

From 11-14 March 2015, Tropical Cyclone Pam, with winds of up to Category 5, hit the Solomon Islands and Vanuatu. At the same time, the Cyclone caused high waves to crash over atoll islands in Kiribati and the Solomon Islands. The super cyclone is one of the worst natural disasters in South Pacific history.

10 Apr 2015

Philips launches connected health technology solutions at HIMSS15

Royal Philips today announced its participation in the 2015 HIMSS Annual Conference & Exhibition (HIMSS15), taking place April 12-16 in Chicago, Ill.

10 Apr 2015

UofL-led study focuses on flu vaccine for children with neurological disorders

Children who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than youngsters without these conditions, despite the increased risk for complications from flu these children experience.

10 Apr 2015

Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%.

9 Apr 2015

Nielsen BioSciences launches skin test that helps physicians manage Valley Fever infections

Nielsen BioSciences announced today the launch of SPHERUSOL (Coccidioides immitis Spherule-Derived Skin Test Antigen), a skin test that provides valuable data to physicians managing Valley Fever infections. SPHERUSOL has been approved by the U.S. Food and Drug Administration as the only skin test to detect an immune response to the fungus called Coccidioides, or "cocci," in patients with history of the disease.

9 Apr 2015

UGR-led scientists defend the role of PE teachers as point of entry to public health system

An international team of scientists led by the University of Granada has defended the role of physical education (PE) teachers in secondary schools as the point of entry to the public health system.

9 Apr 2015

Loyola otolaryngologist offers tips to identify, treat ear infection in children

Earaches in babies are not uncommon. But a baby's inability to communicate symptoms can leave most parents feeling helpless. According to the American Academy of Pediatrics, three-fourths of babies will get at least one ear infection before the age of one.

8 Apr 2015

Researchers reveal molecular structure of cytotoxin from Mycoplasma pneumoniae

Researchers from the School of Medicine at The University of Texas Health Science Center at San Antonio today revealed the molecular structure of the cytotoxin from Mycoplasma pneumoniae, a widespread, highly contagious bacterium that infects the lungs.

8 Apr 2015

Study: Gene variant, urban environment increase risk of severe disease in children infected with RSV

A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus (RSV), an international team of investigators has found.

8 Apr 2015

MRSA bacteria exposed to cigarette smoke become more resistant to antimicrobial peptides

Methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic-resistant superbug, can cause life-threatening skin, bloodstream and surgical site infections or pneumonia. Researchers at the University of California, San Diego School of Medicine now report that cigarette smoke may make matters worse.

3 Apr 2015

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.

2 Apr 2015

Hospitals, health systems preparing to treat patients with Ebola face unexpected challenges

Hospitals and health systems preparing for and treating patients with Ebola Virus Disease (EVD) in the fall of 2015 faced unexpected challenges for ensuring safety of staff, patients and the community. The experiences are detailed in two studies published online in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

2 Apr 2015

New ERS and ATS statement highlights current state, future research directions in COPD

The European Respiratory Society and American Thoracic Society have published a statement describing the current evidence on the diagnosis, assessment and management of chronic obstructive pulmonary disease (COPD), identifying gaps in knowledge and making recommendations for the directions of future research.

1 Apr 2015

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

Lung diseases like emphysema and pulmonary fibrosis are common among people with malfunctioning telomeres, the “caps” or ends of chromosomes. Now, researchers from Johns Hopkins say they have discovered what goes wrong and why.

1 Apr 2015

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

1 Apr 2015

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.

31 Mar 2015

China Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December 31, 2014.

31 Mar 2015

Antibodies from dromedary camels may prove therapeutic for MERS patients

Antibodies from dromedary camels protected uninfected mice from Middle East Respiratory Syndrome (MERS), and helped infected mice expunge the disease, according to a study published online March 18th in the Journal of Virology, a journal published by the American Society for Microbiology.

31 Mar 2015

Respiratory News and Research

New study describes way to regenerate lung tissue after injury

Latest findings regarding nitric oxide offer new avenues to save lives

UNICEF and OFC team up to support children affected by Pacific cyclones

Philips launches connected health technology solutions at HIMSS15

UofL-led study focuses on flu vaccine for children with neurological disorders

Pharmacyclics announces positive results from IMBRUVICA Phase II study in WM patients

Nielsen BioSciences launches skin test that helps physicians manage Valley Fever infections

UGR-led scientists defend the role of PE teachers as point of entry to public health system

Loyola otolaryngologist offers tips to identify, treat ear infection in children

Researchers reveal molecular structure of cytotoxin from Mycoplasma pneumoniae

Study: Gene variant, urban environment increase risk of severe disease in children infected with RSV

MRSA bacteria exposed to cigarette smoke become more resistant to antimicrobial peptides

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Hospitals, health systems preparing to treat patients with Ebola face unexpected challenges

New ERS and ATS statement highlights current state, future research directions in COPD

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

Johns Hopkins researchers find link between premature aging of telomere and lung diseases

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

China Pharma's revenue decreases 24% to $24.9 million in fiscal year 2014

Antibodies from dromedary camels may prove therapeutic for MERS patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News